COVID-19: Challenges, Innovation, and What’s Ahead in 2021
Pharma Marketing Network
OCTOBER 13, 2020
Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?
Let's personalize your content